• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatrics . Severity of Acute COVID-19 in Children <18 Years Old March 2020 to December 2021

tetano

Editor, Senior Moderator
Pediatrics


. 2022 Mar 24;e2021055765.
doi: 10.1542/peds.2021-055765. Online ahead of print.
Severity of Acute COVID-19 in Children <18 Years Old March 2020 to December 2021


Christopher B Forrest[SUP] 1 [/SUP], Evanette K Burrows[SUP] 1 [/SUP], Asuncion Mejias[SUP] 2 [/SUP], Hanieh Razzaghi[SUP] 1 [/SUP], Dimitri Christakis[SUP] 3 [/SUP], Ravi Jhaveri[SUP] 4 [/SUP], Grace M Lee[SUP] 5 [/SUP], Nathan M Pajor[SUP] 6 [/SUP], Suchitra Rao[SUP] 7 [/SUP], Deepika Thacker[SUP] 8 [/SUP], L Charles Bailey[SUP] 1 [/SUP]



Affiliations

Abstract

Background and objectives: High transmissibility of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant led to increased coronavirus disease 2019 (COVID-19) cases, but its effect on severe illness among children is less clear. This study evaluated changes in COVID-19 severity from March 1, 2020, to December 30, 2021.
Methods: We examined electronic health record data from encounters that occurred in outpatient and inpatient settings in 9 health systems participating in PEDSnet. The study sample included children aged <18 years with a positive viral test for SARS-CoV-2. Severity was categorized as asymptomatic, mild (symptoms), moderate (moderately severe COVID-19-related conditions such as gastroenteritis, dehydration, and pneumonia), or severe (unstable COVID-19-related conditions, ICU admission, or mechanical ventilation).
Results: The number of patients classified as asymptomatic was 54 948 (66.4%), with 22 303 (26.9%) being mild, 3781 (4.6%) being moderate, and 1766 (2.1%) being severe. In 2021, patients with moderate to severe illness peaked in June (13.5%), declining to December (8.1%). Compared with July 2020 to February 2021, the adjusted odds ratio for moderate to severe illness was highest in June 2021 (adjusted odds ratio, 2.8; 95% confidence interval, 2.2-3.6) and lower in July to December 2021, when the Delta variant predominated. The adjusted odds ratio for moderate to severe illness among children with complex chronic conditions was 4.2 (95% confidence interval, 3.9-4.5).
Conclusions: Although 1 in 16 children infected with the SARS-CoV-2 virus experienced moderate or severe illness, the risk of severe disease did not change with the emergence of the Delta variant, despite its high transmissibility.
 
Back
Top Bottom